Literature DB >> 16118042

Cytological screening and 15 years' follow-up (1986-2001) for early esophageal squamous cell carcinoma and precancerous lesions in a high-risk population in Anyang County, Henan Province, Northern China.

Li Dong Wang1, Huai Hua Yang, Zong Min Fan, Xiao Dong Lü, Jun Kuan Wang, Xiao Li Liu, Zhe Sun, Ya Nan Jiang, Xin He, Qi Zhou.   

Abstract

BACKGROUND: Anyang County and nearby Linzhou (formerly Linxian) in Henan, Northern China have been well recognized as the highest incidence area for esophageal squamous cell carcinoma (SCC) in the world. SCC remains the leading cause of cancer-related death in these areas and the natural history for esophageal precancerous lesions is not clear.
METHODS: In the present study, to determine the significance of cytological examination and natural history for SCC, esophageal balloon cytological screening and follow-up studies have been performed 2273 symptom-free subjects in Anyang County since 1986. Based on cellular morphological changes, esophageal epithelial cells were classified as normal (NOR), inflammation (IN), hyperplasia (HYP), dysplasia (grades I and II) (DYS I and DYS II), near squamous cell carcinoma (NSCC) and SCC.
RESULTS: The prevalence of NOR, IN, HYP, DYS I, DYS II, and NSCC was 22.7, 3.6, 33.6, 21.5, 10.7, and 3.8%, respectively, in males and 25.8, 5.7, 33, 18.9, 10.4, and 3.8%, respectively in females. No difference was observed between the male and female subjects (p > 0.05). Of the 2273 subjects examined, 2199 subjects entered the final follow-up analysis (97%). During the 15 years' follow-up on these subjects, 94 new cases (4.2%, 94/2199), including 91 with SCC (97%, 91/94, 58 males and 33 females) and 3 with GCA (3%, 3/94, one male and two females) were identified with a mean time of 8 +/- 4.6 years after entry of the follow-up. The incidence for SCC in males was higher than that in females (p < 0.05). The rate for SCC development increased apparently from the groups of NOR (2.4%) to DYS I (5%), DYS II (8.3%), and NSCC (10.3%) (p < 0.001). The prevalence of DYS and NSCC increased significantly with age.
CONCLUSIONS: The present results indicate that esophageal balloon cytology is a reliable approach for early SCC and precancerous lesions screening and that DYS and NSCC are important markers for high-risk subjects with predisposition to SCC. Close follow-up to the subjects with HYP, DYS and NSCC may shed light on the natural history for human esophageal carcinogenesis.

Entities:  

Mesh:

Year:  2005        PMID: 16118042     DOI: 10.1016/j.cdp.2005.06.004

Source DB:  PubMed          Journal:  Cancer Detect Prev        ISSN: 0361-090X


  17 in total

1.  Esophageal squamous cell carcinoma - precursor lesions and early diagnosis.

Authors:  Antonio Barros Lopes; Renato Borges Fagundes
Journal:  World J Gastrointest Endosc       Date:  2012-01-16

2.  Cost-benefit analysis of esophageal cancer endoscopic screening in high-risk areas of China.

Authors:  Juan Yang; Wen-Qiang Wei; Jin Niu; Zhi-Cai Liu; Chun-Xia Yang; You-Lin Qiao
Journal:  World J Gastroenterol       Date:  2012-05-28       Impact factor: 5.742

Review 3.  Screening for oesophageal cancer.

Authors:  Pierre Lao-Sirieix; Rebecca C Fitzgerald
Journal:  Nat Rev Clin Oncol       Date:  2012-03-20       Impact factor: 66.675

Review 4.  Recent Advances in Non-invasive Esophageal Tissue Sampling.

Authors:  David A Katzka
Journal:  Curr Gastroenterol Rep       Date:  2017-03

5.  Cytochrome P450 1A1 (CYP1A1) polymorphism and susceptibility to esophageal cancer: an updated meta-analysis of 27 studies.

Authors:  Feng-Feng Gong; Shan-Shan Lu; Cai-Yun Hu; Zhen-Zhong Qian; Fang Feng; Yi-Le Wu; Hui-Yun Yang; Ye-Huan Sun
Journal:  Tumour Biol       Date:  2014-07-22

Review 6.  Role of TFF3 as an adjunct in the diagnosis of Barrett's esophagus using a minimally invasive esophageal sampling device-The CytospongeTM.

Authors:  Anna L Paterson; Marcel Gehrung; Rebecca C Fitzgerald; Maria O'Donovan
Journal:  Diagn Cytopathol       Date:  2019-12-09       Impact factor: 1.582

7.  Update on endoscopic diagnosis, management and surveillance strategies of esophageal diseases.

Authors:  Fernando Fornari; Rafaela Wagner
Journal:  World J Gastrointest Endosc       Date:  2012-04-16

8.  Combined treatment of oxaliplatin and capecitabine in patients with metastatic esophageal squamous cell cancer.

Authors:  Tian-Jie Qin; Gai-Li An; Xin-Han Zhao; Fang Tian; Xiao-Hua Li; Juan-Wen Lian; Bo-Rong Pan; Shan-Zhi Gu
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

9.  Sponge Sampling with Fluorescent In Situ Hybridization as a Screening Tool for the Early Detection of Esophageal Cancer.

Authors:  Kelly R Haisley; James P Dolan; Susan B Olson; Sergio A Toledo-Valdovinos; Kyle D Hart; Gene Bakis; Brintha K Enestvedt; John G Hunter
Journal:  J Gastrointest Surg       Date:  2016-08-25       Impact factor: 3.452

10.  Elevated expression patterns and tight correlation of the PLCE1 and NF-κB signaling in Kazakh patients with esophageal carcinoma.

Authors:  Xiao-Bin Cui; Xue-Lian Pang; Su Li; Jing Jin; Jian-Ming Hu; Lan Yang; Chun-Xia Liu; Li Li; Shu Jun Wen; Wei-Hua Liang; Yun-Zhao Chen; Feng Li
Journal:  Med Oncol       Date:  2013-12-05       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.